The goals of this hamartoma research proposal overall are to elucidate the molecular signaling pathways that regulate cell size and growth responses involving the tumor suppressor genes TSC1, TSC2, LKB1, and PTEN, and to identify molecular markers and therapeutictargets. The role of this core is to provide critically necessary pathologic materials and pathologic expertise for the review and interpretation of translationof these findings to human hamartoma specimens. This is critically important, because findings fromcellular and mouse model systems must be validated in human clinical specimens. Although there are several translational studies of this kind reported for TSC, there is a remarkable dearth of such studies for Cowden and Peutz-Jeghers syndromes, which correspond to germline mutation in PTEN and LKB1, respectively. In addition, the studies in TSC are limited in scope. Thus, this core will serve a critical role in the development and interpretation ofimmunohistochemical stains that will confirm and extend findings from in vitro studies to human clinical specimens. This core will also serve an important role in the review of pathology seen in the mouse models developed as part of this program, and will also develop and analyze immunohistochemicalstains on rodent tumors that model various aspects of hamartoma development. Thus, our three aims are:
Aim 1. To provide a Human Pathology Core of hamartoma lesions for analysis in collaboration with the Project investigators of this P01.
Aim 2. To develop and perform immunohistochemical studies on human hamartoma specimens, to provide clinical translation of tissue culture and mouse model findings.
Aim 3. To perform immunohistochemicalstudies on pathology specimens from mouse models of TSC and PJS, and derivative models to be generated in this P01 by Projects 1and 2.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Brigham and Women's Hospital
United States
Zip Code
McBrayer, Samuel K; Mayers, Jared R; DiNatale, Gabriel J et al. (2018) Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma. Cell 175:101-116.e25
Kamareddine, Layla; Wong, Adam C N; Vanhove, Audrey S et al. (2018) Activation of Vibrio cholerae quorum sensing promotes survival of an arthropod host. Nat Microbiol 3:243-252
Wu, Shulin; Ye, Jianheng; Wang, Zongwei et al. (2018) Expression of aromatase in tumor related stroma is associated with human bladder cancer progression. Cancer Biol Ther 19:175-180
Ye, Jianheng; Zhang, Yanqiong; Cai, Zhiduan et al. (2018) Increased expression of immediate early response gene 3 protein promotes aggressive progression and predicts poor prognosis in human bladder cancer. BMC Urol 18:82
CaƱadas, Israel; Thummalapalli, Rohit; Kim, Jong Wook et al. (2018) Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses. Nat Med 24:1143-1150
Jenkins, Russell W; Aref, Amir R; Lizotte, Patrick H et al. (2018) Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids. Cancer Discov 8:196-215
Limpert, Allison S; Lambert, Lester J; Bakas, Nicole A et al. (2018) Autophagy in Cancer: Regulation by Small Molecules. Trends Pharmacol Sci 39:1021-1032
Tang, Hong-Wen; Hu, Yanhui; Chen, Chiao-Lin et al. (2018) The TORC1-Regulated CPA Complex Rewires an RNA Processing Network to Drive Autophagy and Metabolic Reprogramming. Cell Metab 27:1040-1054.e8
Cox, Andrew G; Tsomides, Allison; Yimlamai, Dean et al. (2018) Yap regulates glucose utilization and sustains nucleotide synthesis to enable organ growth. EMBO J 37:
Chen, Jingjing; Guccini, Ilaria; Di Mitri, Diletta et al. (2018) Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer. Nat Genet 50:219-228

Showing the most recent 10 out of 289 publications